Motif Bio PLC Exercise of Warrants (2927F)

TIDMMTFB

RNS Number : 2927F

Motif Bio PLC

19 February 2018

Exercise of Warrants

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that it has received notification from a warrant holder to exercise warrants representing 107,142 ordinary shares of 1p each ("Ordinary Shares") in the Company at an exercise price of 32.2p per warrant for total consideration of GBP34,499.22.

Application has been made for the 107,142 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is expected to occur at 8.00 a.m. on 22 February 2018. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Following Admission, and for the purposes of the Disclosure Guidance and Transparency Rules, the Company's total issued share capital will consist of 264,097,872 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.

For further information, please contact:

 
 Motif Bio plc                                                   info@motifbio.com 
 Graham Lumsden (Chief Executive 
  Officer) 
 
 
 Peel Hunt LLP (NOMAD & BROKER)                               + 44 (0)20 7418 8900 
 Dr Christopher Golden 
 Oliver Jackson 
 
 Northland Capital Partners 
  Limited (BROKER)                                             +44 (0)203 861 6625 
 David Hignell/John Howes/ Rob 
  Rees 
 
 Walbrook PR Ltd. (UK FINANCIAL 
  PR & IR)                                                    +44 (0) 20 7933 8780 
 Paul McManus/Helen Cresswell/                        or motifbio@walbrookpr.com 
 Lianne Cawthorne 
 
 MC Services AG (EUROPEAN 
  IR)                                                           +49 (0)89 210 2280 
 Raimund Gabriel                                  raimund.gabriel@mc-services.eu 
 
 The Trout Group (US IR)                                        + 1 (646) 378-2936 
 Meggie Purcell                                            mpurcell@troutgroup.com 
 
 Russo Partners (US PR)                                          +1 (858) 717-2310 
                                                                 +1 (212) 845-4272 
 David Schull                                    david.schull@russopartnersllc.com 
 Travis Kruse, Ph.D.                             travis.kruse@russopartnersllc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSFUFEUFASELE

(END) Dow Jones Newswires

February 19, 2018 07:53 ET (12:53 GMT)

Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Giu 2024 a Lug 2024